Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus

Parasitic illnesses is increasing all over the world, especially in developing countries, and metronidazole (MTZ) is the therapeutic agent usually administered to children as well as adults at the reproductive age. In this work, we propose an evaluation of MTZ in order to analyze the potential repro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Mudry, M.D
Otros Autores: Martinez-Flores, I., Palermo, A.M, Carballo, M.A, Egozcue, J., Garcia Caldes, M.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2001
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 11564caa a22012857a 4500
001 PAPER-20645
003 AR-BaUEN
005 20230518205204.0
008 190411s2001 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0035029506 
024 7 |2 cas  |a Antitrichomonal Agents; Metronidazole, 443-48-1 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a TCMUD 
100 1 |a Mudry, M.D. 
245 1 0 |a Embryolethality induced by metronidazole (MTZ) in Rattus norvegicus 
260 |c 2001 
270 1 0 |m Mudry, M.D.; GIBE-Grupo Inv. Biologia Evolutiva, Depto. de Cs. Biológicas, FCEyN, UBA, Ciudad Universitaria, (1428) Buenos Aires, Argentina; email: mmudry@bg.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Castelli, M., Malagoli, M., Ipazzio Ruberto, A., Baggio, A., Casolari, C.H., Cermelli, C., Bossa, M.R., Roffia, S., In-vitro studies of two 5-nitroimidazole derivatives (1997) J Ant Chemoter, 40, pp. 19-25 
504 |a Cosar, C., Julou, L., Activité de l'(hydroxy-e-ethyl)-1-methyl-2-nitro-5-imidazole (8.823R.P) vis-à-vis des infections expérimentales à Trichomonas vaginalis (1959) Ann Inst Pasteur (Paris), 96, p. 238 
504 |a Burchard, G.D., Mirelman, D., Entamoeba hystolitica: Virulence potential and sensitivity to metronidazole and emetine of four isolates possessing non-pathogenic zymodemes (1988) Exp Parasitol, 66, pp. 231-242 
504 |a Baines, E.I., Metronidazole: Sixteen years of developments (1978), pp. 61-71. , Finegold S, editor. Metronidazole. Amsterdam: Excepta Medica; Ings, R.M.J., McFadzean, J.A., Ormerod, W.E., The mode of action of metronidazole in Trichomona vaginalis and other microorganisms (1974) Biochem Pharmacol, 23, pp. 1421-1429 
504 |a Ludlum, D.B., Colinas, R.J., Kirk, M.C., Mehta, J.R., Reaction of reduced Metronidazole with guanosine to form an unstable adduct (1988) Carcinogenesis, 9, pp. 593-596 
504 |a Mohindra, J.K., Rauth, A.M., Increased cell killing by metronidazole and nitrofurazone of hipoxic compared to aerobic mammalian cells (1976) Cancer Res, 36, pp. 930-936 
504 |a La Russo, N.F., Tomasz, M., Müller, M., Lipman, R., Interaction of metronidazole with nucleic acids "in vitro" (1977) Mol Pharmacol, 13, pp. 872-882 
504 |a Knight, R.C., Skolimowsky, I.M., Edwards, D.J., The interaction of reduced Metronidazole with DNA (1978) Biochem Pharmacol, 27, pp. 2089-2093 
504 |a Probst, G.S., McMahon, R.E., Hill, E.E., Thompson, C.Z., Epp, J.K., Neal, S.B., Chemically-induced unscheduled DNA synthesis in primary rat hepatocyte cultures: A comparison with bacterial mutagenicity using 218 compounds (1981) Environ Mutagen, 3, pp. 11-32 
504 |a Sina, J.F., Bean, C.L., Dysart, G.R., Taylor, V.I., Bradley, M.O., Evaluation of the alkaline elution rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential (1983) Mutation Res, 113, pp. 357-391 
504 |a Mitelman, F., Hartley-Asp, B., Ursing, B., Chromosome aberrations and metronidazole (1976) Lancet, p. 802 
504 |a Hartley-Asp, B., Absence of chromosomal damage in the lymphocytes of patients treated with metronidazole for Trichomonas vaginalis (1979) Toxicol Lett, 4, pp. 15-19 
504 |a Dobías, L., Cerna, M., Rossner, P., Sram, R., Genotoxicity and carcinogenicity of metronidazole (1994) Mutation Res, 317, pp. 177-194 
504 |a Burtin, P., Taddio, A., Ariburnu, O., Einarson, T.R., Koren, G., Safety of metronidazole in pregnancy: A meta-analysis (1995) A. J Obstet Gynecol, 172, pp. 525-529 
504 |a Ivanov, I., The effect of "Trichomonacid" on pregnancy in experimental animals (1969) Akushervo Gynekologya, 8, pp. 241-244 
504 |a Chacko, M., Bhide, S.V., Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice (1986) J Cancer Res, 112, pp. 135-140 
504 |a Giknis, M.L.A., Damjanov, I., The transplacental effects of ethanol and metronidazole in Swiss Webster mice (1983) Toxicol Lett, 19, pp. 37-42 
504 |a Mudry, M., Carballo, M.A., Labal de Vinuesa, M., Larripa, I., Mutagenic bioassays of certain pharmacological drugs: III Metronidazole (MTZ) (1994) Mutation Res, 305, pp. 127-132 
504 |a Cox, B.D., Lyon, M.F., X-ray induced dominant lethal mutations in mature and immature oocytes of guinea pigs and golden hamsters (1975) Mutation Res, 28, pp. 421-436 
504 |a Zar, J., (1984) Biostatistical analysis, 201, pp. 292-298. , New York: Prentice-Hall, Inc 
504 |a Cosar, C., Ganter, P., Julou, L., Étude expérimentale du métronidazole, 8223 RP: Activités trichomonacide et amoebicide. Toxicité et propriétés pharmacologiques générales (1969) Presse Medicale, 69, pp. 1969-1972 
504 |a Jokipii, L., Jokipii, M.M., In vitro susceptibility of Giardia liamblia trophozoites to metronidazole and tinidazole (1980) J Infect Dis, 141, pp. 317-325 
504 |a Freeman, C.D., Klutman, E.N., Lamp, K.C., Metronidazole a therapeuthic review and update (1997) Drugs, 54, pp. 679-708 
504 |a Bergan, T., Arnold, E., Pharmacokinetics of metronidazole in healthy volunteers after tablets and suppositories (1980) Chemotherapy, 26, pp. 231-241 
504 |a Nitsche, V., Mascher, M., Pharmacokinetics of metronidazole after application on different routes (1981) Procedures of the First European Congress on Bipharmacy and Pharmacokinetics, Technique et Documentation, pp. 169-181. , Clermont Ferrand, part Y 
504 |a Mattila, J., Mnnistö, P.T., Mántyla, R., Nykänen, S., Lamminsivi, U., Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route (1983) Antimicrob Agents and Chemother, 23 (5), pp. 721-725 
504 |a Lamp, K.C., Freeman, C.D., Klutman, E.N., Lacy, M.K., Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials (1999) J Clin Pharmacokinet, 36, pp. 353-373 
504 |a Russell, L.B., Russell, W.L., Frequency and nature of specific-locus mutation induced in female mice by radiation and chemicals: A review (1992) Mutation Res, 296, pp. 107-127 
504 |a Kirk, M., Lyon, M.F., Induction of congenital anomalies in offspring of female mice exposed to varying doses of X-rays (1982) Mutation Res, 106, pp. 73-83 
504 |a Martínez-Flores, I., Saez, C., Egozcue, J., Garcia, M., Effects of ionizing radiation on oocytes prepubertally irradiated rats (2000) Int J Radiat Biol 
504 |a Martínez-Flores, I., Saez, C., Egozcue, J., Garcia, M., Effects of female fertility and germinal cells in prepubertal and adult rats (Rattus norvegicus) after X-ray irradiation (1998) Reprod Toxicol, pp. 215-219 
504 |a Bender, M.A., Griggs, H.G., Bedford, J.S., Mechanisms of chromosome aberration production. III. Chemicals and ionizing radiation (1974) Mutation Res, 23, pp. 197-212 
504 |a Edwards, D.I., Rowley, D.A., Knox, R.J., Skolimowski, I.M., Knight, R.C., Nature of DNA-damage induced by electrolytically reduced nitroimidazole drugs (1980), 1, p. 561. , Nelsson JD, Grassi C, editors. Current chemotherapy and infectious disease. Washington DC: The American Society for Microbiology; Reichert, W., Buselmaier, W., Vogel, F., Elimination of X-ray induced chromosomal aberrations in the progeny of female mica (1984) Mutation Res, 139, pp. 87-94 
504 |a Lau, A.H., Lam, N.P., Piscitelli, S.C., Wilkes, L., Danziger, L.H., Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infective (1992) Clin Pharmacokinet, 23, pp. 328-364 
520 3 |a Parasitic illnesses is increasing all over the world, especially in developing countries, and metronidazole (MTZ) is the therapeutic agent usually administered to children as well as adults at the reproductive age. In this work, we propose an evaluation of MTZ in order to analyze the potential reproductive damage in females by using Rattus norvegicus (Sprague-Dawley) as an animal model. Adult female rats were mated after MTZ treatments, and they were sacrificed at 21 days of gestation. Different types of damage were evaluated by using mortality, phenotypic abnormalities and reproductive capacity as parameters, and were studied and scored in 70 adult specimens (450 g/bw). They were divided into five groups: a) untreated females as a control group; females treated with b) DMSO as a solvent control group or c) 500 mg/kg/bw of MTZ per day for 7 days as therapeutic dose (TD); d) a half therapeutic dose (HD); and e) a double therapeutic dose (DD). Pre-implantation death in MTZ-treated groups was not significantly different from controls. However, drug treatments significantly increased the frequency of post-implantation deaths and the dominant lethals were ranged between 12.0 % and 17.8 %. © 2001 Wiley-Liss, Inc.  |l eng 
593 |a GIBE (Grupo de Investigacion en Biologia Evolutiva), Departamento de Biologia, Universidad de Buenos Aires (UBA), Argentina 
593 |a CIGETOX (Centro de Investigaciones en Genetica Toxicologica), Departamento de Bioquimica Clinica, Universidad de Buenos Aires (UBA), Argentina 
593 |a Departament de Biologia Cellular de Fisiologia i Dimmunologia, Unitat de Biologia (Medicina), Universitat Autonoma de Barcelona (UAB), Spain 
593 |a CITEFA, Buenos Aires, Argentina 
593 |a GIBE-Grupo de Inv. en Biologia Evolutiva, Depto. de Cs. Biologicas, Ciudad Universitaria, Pabellon II, (1428) Buenos Aires, Argentina 
690 1 0 |a DOMINANT LETHALITY 
690 1 0 |a MATERNAL EXPOSURE 
690 1 0 |a NITROIMIDAZOLE 
690 1 0 |a POST-IMPLANTATION DEATH 
690 1 0 |a METRONIDAZOLE 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a EMBRYOTOXICITY 
690 1 0 |a ENVIRONMENTAL EXPOSURE 
690 1 0 |a FEMALE 
690 1 0 |a GESTATIONAL AGE 
690 1 0 |a MORTALITY 
690 1 0 |a NIDATION 
690 1 0 |a NONHUMAN 
690 1 0 |a PHENOTYPE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a RAT 
690 1 0 |a REPRODUCTION 
690 1 0 |a ANIMALS 
690 1 0 |a ANTITRICHOMONAL AGENTS 
690 1 0 |a EMBRYO 
690 1 0 |a EMBRYO IMPLANTATION 
690 1 0 |a EMBRYO LOSS 
690 1 0 |a EMBRYONIC DEVELOPMENT 
690 1 0 |a FEMALE 
690 1 0 |a FERTILITY 
690 1 0 |a FETAL DEATH 
690 1 0 |a FETUS 
690 1 0 |a MATERNAL EXPOSURE 
690 1 0 |a METRONIDAZOLE 
690 1 0 |a PREGNANCY 
690 1 0 |a RATS 
690 1 0 |a RATS, SPRAGUE-DAWLEY 
690 1 0 |a REPRODUCTION 
690 1 0 |a ANIMALIA 
690 1 0 |a RATTUS NORVEGICUS 
700 1 |a Martinez-Flores, I. 
700 1 |a Palermo, A.M. 
700 1 |a Carballo, M.A. 
700 1 |a Egozcue, J. 
700 1 |a Garcia Caldes, M. 
773 0 |d 2001  |g v. 21  |h pp. 197-205  |k n. 3  |p Teratog. Carcinog. Mutag.  |x 02703211  |t Teratogenesis Carcinogenesis and Mutagenesis 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035029506&doi=10.1002%2ftcm.1008&partnerID=40&md5=977bc0661329fd48b4c4d30815782225  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1002/tcm.1008  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_02703211_v21_n3_p197_Mudry  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02703211_v21_n3_p197_Mudry  |y Registro en la Biblioteca Digital 
961 |a paper_02703211_v21_n3_p197_Mudry  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 81598